Acute coronary syndrome: the challenge of identifying low-risk patients

Reliable identification of patients who have presented with symptoms of ACS and are at low risk for serious clinical events is beneficial to both patients and the healthcare system. Methods to achieve this are needed as clinical gestalt alone cannot reliably define those patients with serious clinical event rates below 1% at 30 days.